Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Versican, a protein, is less present in thinning hair follicles and this decrease might contribute to common hair loss in men.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Inhibiting Zyxin may help treat androgenetic alopecia by promoting hair growth.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

Genes and hormones cause hair loss, with four genes contributing equally.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Methyl vanillate spray increases hair count and hair mass in women with hair loss.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

EDA2R gene linked to hair loss.

Genetic marker rs12558842 strongly linked to male hair loss.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Certain gene variations are linked to severe acne in Egyptian patients and could guide treatment choices.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Androgens cause oil-producing skin cells with androgen receptors to mature and produce more oil.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.